Group 1: Pharmaceutical Sector - The pharmaceutical sector faced significant negative impacts following President Trump's announcement to reduce drug prices to 1/1400 to 1/1500 of current levels and impose tariffs on drugs [1][5]. - Major pharmaceutical companies experienced stock declines, with DexCom dropping over 7.6%, Moderna down 6.53%, Pfizer down 2.86%, and Merck down 2.36% after Trump's remarks [5]. Group 2: Intel and Government Stake - Intel's stock fell by 1.01% as the company warned that the U.S. government's 10% stake could pose risks to its business, potentially harming international sales and limiting future government subsidies [3]. - The agreement for the U.S. government to acquire 9.9% of Intel's shares was based on unspent subsidies totaling $5.7 billion, with the purchase price set at $20.80, which is $4 lower than the previous closing price of $24.80 [3].
突发利空！美医药股，大跌！
Zheng Quan Shi Bao·2025-08-26 00:07